Nurix Therapeutics, Inc. NRIX Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s total operating expenses?
- Nurix Therapeutics, Inc. (NRIX) reported total operating expenses of $98.75M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Nurix Therapeutics, Inc.'s total operating expenses increased by 21.4% year-over-year, from $81.32M to $98.75M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s total operating expenses has grown at a 25.8% compound annual growth rate (CAGR), from $147.64M to $369.65M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.